Stopspasm 20 tablets

Tradename

Stop spasm

Stopspasm

Composition

Each tablet contains:

Phloroglucinol 62 mg.

Trimethyl Phloroglucinol 80 mg.

Auxiliary components:

Lactose monohydrate, PVP K25 corn starch, microcrystalline cellulose, magnesium stearate, hydroxypropyl methylcellulose, titanium dioxide, macrogol 6000, carmosine Al.

Properties

Treatment of spasms that occur in smooth muscle tissues. The drug has a myotropic effect on smooth muscle tissues, although its advantage over papaverine is that it has no effect on the cardiovascular system. None of the pharmacological studies have shown cholinergic effects. Thus, no undesirable atropine-like effects were observed in patients; this is a clear advantage over other antispasmodic drugs.

Indications

Symptomatic treatment of pain associated with functional disorders of the digestive tract and biliary tract. Treatment of spastic and painful manifestations of diseases of the urinary tract, for example, renal colic.

Symptomatic treatment of spasmodic painful phenomena in gynecology.

Method of administration and dosage:

Contraindications

Hypersensitivity to the components of the drug.

Precautions:

The combination of phloroglucinol with major pain relievers such as morphine or its derivatives should be avoided due to their spasmodic effects.

Side effects

Allergic reactions are possible.

Storage method:

At a temperature not higher than 30 degrees.